The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/bmri/volume-2017/9643139/figures/9643139.fig.002a.svgz" name="9643139.fig.002a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>ROC curves in BC group</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/bmri/volume-2017/9643139/figures/9643139.fig.002b.svgz" name="9643139.fig.002b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>ROC curves in subgroup SA</td></tr></table>

<div>Receiving operating characteristic (ROC) analysis of NMP22, BLCA-4, NMBL, GST<i>π</i>, and 8-OHdG level in whole BC group (a) and SA subgroup (b).</div>

BioMed Research International

fig2

Figure 2

Figure 2: The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens 